RUNX1 and acute myeloid leukemia: The role of alternative splicing (AS) in AML pathogenesis was first highlighted by Tanaka et al. (1995) [36] who analyzed two of three previously identified alternative isoforms of AML1 gene, at present termed RUNX1.